Literature DB >> 25782906

Risk factors for central-line-associated bloodstream infections: a focus on comorbid conditions.

Christopher S Pepin1, Kerri A Thom1, John D Sorkin2, Surbhi Leekha1, Max Masnick1, Michael Anne Preas3, Lisa Pineles1, Anthony D Harris1.   

Abstract

Centers for Disease Control and Prevention (CDC) risk adjustment methods for central-line-associated bloodstream infections (CLABSI) only adjust for type of intensive care unit (ICU). This cohort study explored risk factors for CLABSI using 2 comorbidity classification schemes, the Charlson Comorbidity Index (CCI) and the Chronic Disease Score (CDS). Our study supports the need for additional research into risk factors for CLABSI, including electronically available comorbid conditions.

Entities:  

Mesh：

Year:  2015        PMID： 25782906      PMCID： PMC4367124          DOI： 10.1017/ice.2014.81

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  9 in total

1.  National Healthcare Safety Network (NHSN) Report, data summary for 2010, device-associated module.

Authors:  Margaret A Dudeck; Teresa C Horan; Kelly D Peterson; Katherine Allen-Bridson; Gloria Morrell; Daniel A Pollock; Jonathan R Edwards
Journal:  Am J Infect Control       Date:  2011-12       Impact factor: 2.918

Review 2.  Risk factors for surgical site infections after breast surgery: a systematic review and meta-analysis.

Authors:  D Q Xue; C Qian; L Yang; X F Wang
Journal:  Eur J Surg Oncol       Date:  2012-03-14       Impact factor: 4.424

3.  "But my patients are different!": risk adjustment in 2012 and beyond.

Authors:  Rebekah W Moehring; Deverick J Anderson
Journal:  Infect Control Hosp Epidemiol       Date:  2011-09-01       Impact factor: 3.254

4.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

5.  A chronic disease score from automated pharmacy data.

Authors:  M Von Korff; E H Wagner; K Saunders
Journal:  J Clin Epidemiol       Date:  1992-02       Impact factor: 6.437

6.  Does the Centers for Disease Control's NNIS system risk index stratify patients undergoing cardiothoracic operations by their risk of surgical-site infection?

Authors:  M C Roy; L A Herwaldt; R Embrey; K Kuhns; R P Wenzel; T M Perl
Journal:  Infect Control Hosp Epidemiol       Date:  2000-03       Impact factor: 3.254

7.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

8.  Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections.

Authors:  Jessina C McGregor; Eli N Perencevich; Jon P Furuno; Patricia Langenberg; Kathleen Flannery; Jingkun Zhu; Jeffrey C Fink; Douglas D Bradham; Anthony D Harris
Journal:  J Clin Epidemiol       Date:  2006-08-10       Impact factor: 6.437

9.  Developing a risk stratification model for surgical site infection after abdominal hysterectomy.

Authors:  Margaret A Olsen; James Higham-Kessler; Deborah S Yokoe; Anne M Butler; Johanna Vostok; Kurt B Stevenson; Yosef Khan; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2009-11       Impact factor: 3.254
  9 in total
  9 in total

1.  Which Comorbid Conditions Should We Be Analyzing as Risk Factors for Healthcare-Associated Infections?

Authors:  Anthony D Harris; Lisa Pineles; Deverick Anderson; Keith F Woeltje; William E Trick; Keith S Kaye; Deborah S Yokoe; Ann-Christine Nyquist; David P Calfee; Surbhi Leekha
Journal:  Infect Control Hosp Epidemiol       Date:  2016-12-29       Impact factor: 3.254

2.  Central line-associated bloodstream infections at the multidisciplinary intensive care unit of Universitas Academic Hospital, Bloemfontein, South Africa.

Authors:  E Glover; A Abrahamson; J Adams; S R Poken; S-L Hainsworth; A Lamprecht; T Delport; T Keulder; T Olivier; S D Maasdorp
Journal:  Afr J Thorac Crit Care Med       Date:  2022-05-05

3.  Electronically Available Comorbid Conditions for Risk Prediction of Healthcare-Associated Clostridium difficile Infection.

Authors:  Anthony D Harris; Alyssa N Sbarra; Surbhi Leekha; Sarah S Jackson; J Kristie Johnson; Lisa Pineles; Kerri A Thom
Journal:  Infect Control Hosp Epidemiol       Date:  2018-02-05       Impact factor: 3.254

4.  Pseudomonas aeruginosa Colonization in the Intensive Care Unit: Prevalence, Risk Factors, and Clinical Outcomes.

Authors:  Anthony D Harris; Sarah S Jackson; Gwen Robinson; Lisa Pineles; Surbhi Leekha; Kerri A Thom; Yuan Wang; Michelle Doll; Melinda M Pettigrew; J Kristie Johnson
Journal:  Infect Control Hosp Epidemiol       Date:  2016-02-01       Impact factor: 3.254

5.  A quality assurance investigation of CLABSI events: are there exceptions to never?

Authors:  Samantha Strickler; Rohit R Gupta; John T Doucette; Roopa Kohli-Seth
Journal:  J Infect Prev       Date:  2017-07-28

6.  Comorbidity and severity-of-illness risk adjustment for hospital-onset Clostridioides difficile infection using data from the electronic medical record.

Authors:  Stephanie M Cabral; Katherine E Goodman; Natalia Blanco; Surbhi Leekha; Larry S Magder; Gita Nadimpalli; Lisa Pineles; Kerri A Thom; Anthony D Harris
Journal:  Infect Control Hosp Epidemiol       Date:  2020-12-17       Impact factor: 6.520

7.  Problematic Risk Adjustment in National Healthcare Safety Network Measures.

Authors:  Richard L Fuller; John S Hughes; Graham Atkinson; Barbara S Aubry
Journal:  Am J Med Qual       Date:  2019-06-27       Impact factor: 1.852

8.  The Impact of Automated Electronic Surveillance of Electronic Medical Records on Pediatric Inpatient Care.

Authors:  Jais Emmanuel; Adalberto Torres
Journal:  Cureus       Date:  2018-10-01

Review 9.  Repeat gram-negative hospital-acquired infections and antibiotic susceptibility: A systematic review.

Authors:  Mansi Agarwal; Stephanie Shiau; Elaine L Larson
Journal:  J Infect Public Health       Date:  2017-10-20       Impact factor: 3.718
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.